"It has been a transformative 12 months for Mediar, from our deal with Eli Lilly and Company on MTX-463, to this oversubscribed Series B financing with leading biotech investors," said Rahul Ballal, ...
MTX-474 Global Phase 2a study Initiated in Systemic Sclerosis (SSc) MTX-463 Global Phase 2a Study in Idiopathic Pulmonary Fibrosis (IPF) Enrolling & Partnered with Lilly MTX-439 Advancing to Phase 1 ...
BOSTON, Jan. 7, 2026 /PRNewswire/ -- Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced an oversubscribed ...
ImageMagick is a powerful image manipulation library that supports over 100 major file formats (not including sub-formats). With Magick.NET you can use ImageMagick in your C#/VB.NET/.NET Core ...
This library allows you to interact with Docker Remote API endpoints in your .NET applications. It is fully asynchronous, designed to be non-blocking and object-oriented way to interact with your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback